TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug Resistance

Objective To investigate the expression level of TEC, a no-receptor tyrosine kinase, in hepatocellular carcinoma(HCC) tissues and its correlation with drug resistance. Methods The expressions of TEC mRNA and protein in carcinoma tissues, paracancerous tissues and HepG2 cell line were determined by R...

Full description

Bibliographic Details
Main Authors: LIU Wen, LI Feifei, ZHONG Minggui, LIU Yakun, FANG Haoshu, WANG Siying
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2018-09-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2018.18.0107.htm
_version_ 1818907668588265472
author LIU Wen
LI Feifei
ZHONG Minggui
LIU Yakun
FANG Haoshu
WANG Siying
author_facet LIU Wen
LI Feifei
ZHONG Minggui
LIU Yakun
FANG Haoshu
WANG Siying
author_sort LIU Wen
collection DOAJ
description Objective To investigate the expression level of TEC, a no-receptor tyrosine kinase, in hepatocellular carcinoma(HCC) tissues and its correlation with drug resistance. Methods The expressions of TEC mRNA and protein in carcinoma tissues, paracancerous tissues and HepG2 cell line were determined by RT-PCR, Western blot, immunohistochemistrical staining and slot blotting. MTT assay was used to detect the activity of HepG2 cells. A eukaryotic expression vector carrying TEC gene was constructed to obtain high expression level of TEC in HCC, and RNA interference was applied to knock down TEC. Phospho-TEC was also analyzed by CO-IP to determine TEC activation. Results TEC mRNA and protein were both increased significantly in 18 cases of HCC tissues as compared with those in paracancerous tissues(P < 0.001). The high expression of TEC was associated with the increased resistance of 48 cases of HCC tissues to chemotherapeutic drugs; the upregulation of TEC increased the resistance of HepG2 cells to chemotherapeutic drugs. TEC were augmented by the treatment of chemotherapeutics, accompanying with an increase of phospho-ERK. Conclusion TEC is highly expressed in HCC tissues, which is responsible for the drug resistance of HCC and likely related to increased phospho-ERK.
first_indexed 2024-12-19T21:58:47Z
format Article
id doaj.art-8a0619921f524222974108a800284a59
institution Directory Open Access Journal
issn 1000-8578
1000-8578
language zho
last_indexed 2024-12-19T21:58:47Z
publishDate 2018-09-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj.art-8a0619921f524222974108a800284a592022-12-21T20:04:12ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85781000-85782018-09-0145966066510.3971/j.issn.1000-8578.2018.18.01078578.2018.18.0107TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug ResistanceLIU Wen0LI Feifei1ZHONG Minggui2LIU Yakun3FANG Haoshu4WANG Siying5Staff Room of Pathology, Department of Elementary Teaching, Anhui College of Traditional Chinese Medicine, Wuhu 241000, ChinaPathophysiology Department, School of Basic Medical Science, Anhui Medical University, Hefei 230032, ChinaPathophysiology Department, School of Basic Medical Science, Anhui Medical University, Hefei 230032, ChinaPathophysiology Department, School of Basic Medical Science, Anhui Medical University, Hefei 230032, ChinaPathophysiology Department, School of Basic Medical Science, Anhui Medical University, Hefei 230032, ChinaPathophysiology Department, School of Basic Medical Science, Anhui Medical University, Hefei 230032, ChinaObjective To investigate the expression level of TEC, a no-receptor tyrosine kinase, in hepatocellular carcinoma(HCC) tissues and its correlation with drug resistance. Methods The expressions of TEC mRNA and protein in carcinoma tissues, paracancerous tissues and HepG2 cell line were determined by RT-PCR, Western blot, immunohistochemistrical staining and slot blotting. MTT assay was used to detect the activity of HepG2 cells. A eukaryotic expression vector carrying TEC gene was constructed to obtain high expression level of TEC in HCC, and RNA interference was applied to knock down TEC. Phospho-TEC was also analyzed by CO-IP to determine TEC activation. Results TEC mRNA and protein were both increased significantly in 18 cases of HCC tissues as compared with those in paracancerous tissues(P < 0.001). The high expression of TEC was associated with the increased resistance of 48 cases of HCC tissues to chemotherapeutic drugs; the upregulation of TEC increased the resistance of HepG2 cells to chemotherapeutic drugs. TEC were augmented by the treatment of chemotherapeutics, accompanying with an increase of phospho-ERK. Conclusion TEC is highly expressed in HCC tissues, which is responsible for the drug resistance of HCC and likely related to increased phospho-ERK.http://html.rhhz.net/ZLFZYJ/html/8578.2018.18.0107.htmhepatocellular carcinomatumor drug resistanceprotein kinasetec
spellingShingle LIU Wen
LI Feifei
ZHONG Minggui
LIU Yakun
FANG Haoshu
WANG Siying
TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug Resistance
Zhongliu Fangzhi Yanjiu
hepatocellular carcinoma
tumor drug resistance
protein kinase
tec
title TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug Resistance
title_full TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug Resistance
title_fullStr TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug Resistance
title_full_unstemmed TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug Resistance
title_short TEC Expresses Highly in Hepatocellular Carcinoma and Is Involved in Drug Resistance
title_sort tec expresses highly in hepatocellular carcinoma and is involved in drug resistance
topic hepatocellular carcinoma
tumor drug resistance
protein kinase
tec
url http://html.rhhz.net/ZLFZYJ/html/8578.2018.18.0107.htm
work_keys_str_mv AT liuwen tecexpresseshighlyinhepatocellularcarcinomaandisinvolvedindrugresistance
AT lifeifei tecexpresseshighlyinhepatocellularcarcinomaandisinvolvedindrugresistance
AT zhongminggui tecexpresseshighlyinhepatocellularcarcinomaandisinvolvedindrugresistance
AT liuyakun tecexpresseshighlyinhepatocellularcarcinomaandisinvolvedindrugresistance
AT fanghaoshu tecexpresseshighlyinhepatocellularcarcinomaandisinvolvedindrugresistance
AT wangsiying tecexpresseshighlyinhepatocellularcarcinomaandisinvolvedindrugresistance